TITLE

Primary Lymphoma of the Breast: A Case of Marginal Zone B-Cell Lymphoma

AUTHOR(S)
Giron, Gladys L.; Hamlin, Paul A.; Brogi, Edi; Mendez, Jane E.; Sclafani, Lisa
PUB. DATE
August 2004
SOURCE
American Surgeon;Aug2004, Vol. 70 Issue 8, p720
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
A case of primary marginal zone B-cell lymphoma in an elderly female patient is presented. Primary breast lymphomas are rare, comprising less than 1 per cent of all breast malignancies. These tumors have no clinical, pathologic, or radiologic pathognomonic features to distinguish them from breast adenocarcinoma. The diagnosis is usually made with an excisional biopsy, and more extensive surgery should be avoided. Delivery of radiation therapy and chemotherapy is tailored according to the histologic grade, stage of disease, and overall patient condition. This report summarizes the current knowledge reflected in the literature.
ACCESSION #
14146692

 

Related Articles

  • Anaplastic Large Cell Lymphoma Arising in a Silicone Breast Implant Capsule. Sahoo, Sunati; Rosen, Paul P.; Feddersen, Richard M.; Viswanatha, David S.; Clark, Douglas A.; Chadburn, Amy // Archives of Pathology & Laboratory Medicine;Mar2003, Vol. 127 Issue 3, pe115 

    Anaplastic large cell lymphoma is a rare type of primary breast lymphoma. We report a case of anaplastic large cell lymphoma, T-cell phenotype, occurring in the periprosthetic capsule of a silicone breast prosthesis 9 years after implantation for augmentation mammoplasty. This case is unique for...

  • BCRP gene polymorphisms are associated with susceptibility and survival of diffuse large B-cell lymphoma. Li-Li Hu; Xiao-Xiao Wang; Xiaochao Chen; Jianhua Chang; Caixia Li; Yan Zhang; Jine Yang; Wenqi Jiang; Shi-Mei Zhuang // Carcinogenesis;Aug2007, Vol. 28 Issue 8, p1740 

    To date, the biological significance of breast cancer resistance protein (BCRP) G34A and C421A polymorphisms is largely unknown. Analysis of these two polymorphisms in 156 diffuse large B-cell lymphoma (DLBCL) patients and 376 control subjects revealed an increased risk of DLBCL associated with...

  • Corixa and GSK deliver results of two studies of Bexxar on non-Hodgkin's lymphoma.  // PharmaWatch: Cancer;July 2004, Vol. 3 Issue 7, p13 

    Reports on research presented by Corixa and GlaxoSmithKline on therapy with two different standard chemotherapeutic regimens, each followed by a single treatment with the Bexxar therapeutic regimen given as initial treatment for advanced follicular B-cell non-Hodgkin's lymphoma. Complete...

  • Durable remission induced by rituximab-containing chemotherapy in a patient with primary refractory Burkitt's lymphoma. Yokohama, A.; Tsukamoto, N.; Uchiumi, H.; Handa, H.; Matsushima, T.; Karasawa, M.; Murakami, H.; Nojima, Y. // Annals of Hematology;Feb2004, Vol. 83 Issue 2, p120 

    We describe a 65-year-old man diagnosed with Burkitt's lymphoma arising from the intestine. The tumor cells had a mature B-cell immunophenotype and rearrangement of the c-myc gene. The patient was treated with intensive multiagent chemotherapy. After four courses of chemotherapy, an ileus...

  • Hematopoietic SCT for peripheral T-cell lymphoma. Gutiérrez, A.; Caballero, M. D.; Pérez-Manga, G.; Rodriguez, J. // Bone Marrow Transplantation;Dec2008, Vol. 42 Issue 12, p773 

    Results of conventional chemotherapy for high-risk peripheral T-cell lymphoma (PTCL) are poor compared with those for their aggressive B-cell counterparts. We aim to review the current data on the use of hematopoietic SCT in these patients in both frontline and salvage settings. With respect to...

  • Efficacy of chemotherapy as a first-line treatment in ocular adnexal extranodal marginal zone B-cell lymphoma. E.-K. Song; S.-Y. Kim; T. M. Kim; K.-W. Lee; T. Yun; I.-I. Na; H. Shin; S. H. Lee; D. W. Kim; S. I. Khwarg; D. S. Heo // Annals of Oncology;Feb2008, Vol. 19 Issue 2, p242 

    Background: Radiotherapy is commonly used as a first-line treatment for localized ocular adnexal extranodal marginal zone B-cell lymphoma (EMZBL), despite its ophthalmologic complications. This study was undertaken to analyze the efficacy of first-line chemotherapy in treating EMZBL....

  • Prostate Involvement by Intravascular Large B-Cell Lymphoma: A Case Report With Literature Review. Xu, Man; Yang, Qingping; Li, Mingxu; Geng, Weipu; Huang, Wenlian; Chen, Yu // International Journal of Surgical Pathology;Aug2011, Vol. 19 Issue 4, p544 

    Prostate involvement by intravascular large B-cell lymphoma (IVLBL) is extremely rare. Until now, only 6 cases have been reported in the literature. In this article, the authors report a case of a 65-year-old Chinese man with IVLBL located in the prostate. The diagnosis of IVLBL was obtained...

  • Primary bone lymphoma: A report of two cases and review of the literature. Singh, Tejinder; Satheesh, C. T.; Lakshmaiah, K. C.; Suresh, T. M.; Babu, Govind K.; Lokanatha, D.; Jacob, Linu A.; Halkud, Rajashekar // Journal of Cancer Research & Therapeutics;Jul-Sep2010, Vol. 6 Issue 3, p296 

    Primary bone lymphoma (PBL) is an uncommon tumor accounting for approximately 4-5% of extra nodal lymphoma and less than 1% of all non-Hodgkin's lymphoma. Disease may be complicated at presentation by pathological fracture or spinal cord compression. Diffuse large-B-cell lymphoma (DLBCL)...

  • Extranodal Marginal Zone Lymphoma Occurring along the Trachea and Central Airway. Ji Young Kang; Hyun Jin Park; Kyo-young Lee; Sook Young Lee; Seung Joon Kim; Sung Hak Park; Young Kyoon Kim // Yonsei Medical Journal;10/31/2008, Vol. 49 Issue 5, p860 

    Extranodal marginal zone lymphoma is a low-grade B cell lymphoma that presents with an indolent clinicopathologic nature. Although this tumor can occur in various sites, including the gastrointestinal tract and lungs, it develops and spreads extremely rarely along the trachea and central airway....

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics